Application of Hildebrand Solubility Parameter to Identify Ethanol-Free Co-Solvent for Pediatric Formulation

IF 0.7 Q4 PHARMACOLOGY & PHARMACY INDONESIAN JOURNAL OF PHARMACY Pub Date : 2023-05-02 DOI:10.22146/ijp.6627
M. Laksitorini, H. Purnomo
{"title":"Application of Hildebrand Solubility Parameter to Identify Ethanol-Free Co-Solvent for Pediatric Formulation","authors":"M. Laksitorini, H. Purnomo","doi":"10.22146/ijp.6627","DOIUrl":null,"url":null,"abstract":"Formulation of active pharmaceutical ingredients into liquid dosage form is frequently limited by solubility issues. Ethanol is commonly used as a cosolvent to improve the solubility of drugs. Due to the incomplete expression of ethanol metabolizing enzyme in children under 6 years, several drug authorities such as WHO, EMA, and FDA recommend avoiding the use of ethanol in pediatric formulation whenever possible. In addition to that Muslim consumers are regulated by the halal practice where excessive use of ethanol in pharmaceutical products should be avoided. Thus, it is necessary to explore an alternative co-solvent to reduce the use of ethanol in the pediatric formulation. This study is aimed to identify an alternative co-solvent to ethanol that is safe for the pediatric using Hildebrand Solubility Parameter approach. \nIn this study, the solubility parameter of the model drug, MH2011, was determined using Hildebrand Solubility Parameter (HSP). The solubility parameter (δ) of MH2011 was determined using two approaches. The first method is by measuring the maximum solubility of the model drugs in the binary mixture of water and 1,4 dioxane. The second approach is by calculating solubility parameters based on Fedor’s group substitution method. \nUsing binary solvent blend, the MH2011 solubility parameter was identified to be approximately 14.0 (cal/cm3 )½. This value is in agreement with the result of the second approach using Fedor’s Group substitution method which is 14. 4 (cal/cm3) ½. With this data, an alternate co-solvent to substitute ethanol was explored. The studies also suggested that propylene glycol 7% v/v may give solubility power as those of ethanol 7% (v/v). This study suggested that Hildebrand’s Solubility Parameter can be applied to identify an alternate co-solvent to ethanol. This cosolvent is important for the research area where the alcohol-free formulation is preferred such as in halal pharmaceuticals and pediatric liquid formulation.","PeriodicalId":13520,"journal":{"name":"INDONESIAN JOURNAL OF PHARMACY","volume":null,"pages":null},"PeriodicalIF":0.7000,"publicationDate":"2023-05-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"INDONESIAN JOURNAL OF PHARMACY","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.22146/ijp.6627","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

Abstract

Formulation of active pharmaceutical ingredients into liquid dosage form is frequently limited by solubility issues. Ethanol is commonly used as a cosolvent to improve the solubility of drugs. Due to the incomplete expression of ethanol metabolizing enzyme in children under 6 years, several drug authorities such as WHO, EMA, and FDA recommend avoiding the use of ethanol in pediatric formulation whenever possible. In addition to that Muslim consumers are regulated by the halal practice where excessive use of ethanol in pharmaceutical products should be avoided. Thus, it is necessary to explore an alternative co-solvent to reduce the use of ethanol in the pediatric formulation. This study is aimed to identify an alternative co-solvent to ethanol that is safe for the pediatric using Hildebrand Solubility Parameter approach. In this study, the solubility parameter of the model drug, MH2011, was determined using Hildebrand Solubility Parameter (HSP). The solubility parameter (δ) of MH2011 was determined using two approaches. The first method is by measuring the maximum solubility of the model drugs in the binary mixture of water and 1,4 dioxane. The second approach is by calculating solubility parameters based on Fedor’s group substitution method. Using binary solvent blend, the MH2011 solubility parameter was identified to be approximately 14.0 (cal/cm3 )½. This value is in agreement with the result of the second approach using Fedor’s Group substitution method which is 14. 4 (cal/cm3) ½. With this data, an alternate co-solvent to substitute ethanol was explored. The studies also suggested that propylene glycol 7% v/v may give solubility power as those of ethanol 7% (v/v). This study suggested that Hildebrand’s Solubility Parameter can be applied to identify an alternate co-solvent to ethanol. This cosolvent is important for the research area where the alcohol-free formulation is preferred such as in halal pharmaceuticals and pediatric liquid formulation.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
希尔德布兰德溶解度参数在儿科配方无乙醇助溶剂鉴定中的应用
将活性药物成分配制成液体剂型经常受到溶解度问题的限制。乙醇常被用作助溶剂来提高药物的溶解度。由于6岁以下儿童的乙醇代谢酶表达不完全,一些药物监管机构,如WHO、EMA和FDA建议尽可能避免在儿科配方中使用乙醇。此外,穆斯林消费者受到清真做法的监管,在药品中应避免过度使用乙醇。因此,有必要探索一种替代的助溶剂,以减少乙醇在儿科配方中的使用。本研究旨在使用希尔德布兰德溶解度参数方法确定一种对儿童安全的乙醇替代助溶剂。本研究采用希尔德布兰德溶解度参数(Hildebrand soluble parameter, HSP)测定模型药物MH2011的溶解度参数。采用两种方法测定MH2011的溶解度参数δ。第一种方法是通过测量模型药物在水和1,4二氧六环二元混合物中的最大溶解度。第二种方法是基于Fedor基团取代法计算溶解度参数。使用二元溶剂混合物,MH2011的溶解度参数约为14.0 (cal/cm3)½。该值与第二种方法使用Fedor的群替换法的结果一致,即14。4 (cal/cm3)½。在此基础上,探索了一种替代乙醇的助溶剂。研究还表明,丙二醇7% v/v的溶解度与乙醇7% (v/v)的溶解度相同。本研究表明,希尔德布兰德溶解度参数可用于确定乙醇的替代共溶剂。这种共溶剂是重要的研究领域,其中无酒精配方是首选,如在清真药品和儿科液体配方。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
INDONESIAN JOURNAL OF PHARMACY
INDONESIAN JOURNAL OF PHARMACY PHARMACOLOGY & PHARMACY-
CiteScore
1.20
自引率
0.00%
发文量
38
审稿时长
12 weeks
期刊介绍: The journal had been established in 1972, and online publication was begun in 2008. Since 2012, the journal has been published in English by Faculty of Pharmacy Universitas Gadjah Mada (UGM) Yogyakarta Indonesia in collaboration with IAI (Ikatan Apoteker Indonesia or Indonesian Pharmacist Association) and only receives manuscripts in English. Indonesian Journal of Pharmacy is Accredited by Directorate General of Higher Education. The journal includes various fields of pharmaceuticals sciences such as: -Pharmacology and Toxicology -Pharmacokinetics -Community and Clinical Pharmacy -Pharmaceutical Chemistry -Pharmaceutical Biology -Pharmaceutics -Pharmaceutical Technology -Biopharmaceutics -Pharmaceutical Microbiology and Biotechnology -Alternative medicines.
期刊最新文献
Effectiveness of Educational Interventions to Improve Knowledge and Medication Adherence for People with Schizophrenia: A Systematic Review Study of 1-Formyl-2-Pyrazolines as Anticancer Drug Candidates Knowledge and Attitude among Community Pharmacists regarding Pharmacovigilance – A Cross Sectional Survey Nephroprotective effect of ethanol extract Abelmoschus manihot l. Leaves in gentamicin-induced mice Cytotoxicity Screening of Endophytic Fungi from Phaleria macrocarpa (Scheff) Boerl) Collected in Yogyakarta District
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1